Bivalent Covid-19 vaccines gaining traction in the West


By AGENCY

Vaccines that target both the original SARS-CoV-2 viral strain and the Omicron variant are rapidly being approved by health authorities around the world. — AFP

France became the latest country on Sept 20 (2022) to authorise new Covid-19 vaccines that have been updated to target the SARS-CoV-2 Omicron viral subvariants ahead of the autumn booster campaign.

Here's what you need to know about these "bivalent" vaccines, which means they also still target the original strain that emerged in the Chinese city of Wuhan in 2019.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Health

Does taking vitamin C when you're sick really work?
Why rescue blankets have a silver and a gold side
'Engage your core!' – but how do you really do that?
Region-specific diets around China recommended to combat obesity
It’s tough becoming a dad – and they get little support too
A tired brain leads to bad decisions and bad behaviour
Diabetes: Empowering communities with peer support and social media
Lower your blood pressure by swapping just a few minutes of sitting for exercise
When uncontrolled diabetes causes you to go blind
New ways to combat the threat of antimicrobial resistance (AMR)

Others Also Read